Infliximab biosimilar is under clinical development by Celltrion and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Vitamin B12 is crucial for red blood cell production, DNA synthesis, and neurological function. Its absorption, a complex ...

NO festive gathering is complete without a feast, desserts and plenty of holiday drinks. But while these celebrations are exciting, they can be hard on our stomachs, often leading to that familiar ...

Divine Gol n Win best win percentage cricket captain Takeda's Entyvio SC achieves success in Phase III clinical tri ...

After living with a condition for eight years, most people would learn to understand how it affects their body, but with ...

Managing inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may soon become more advanced and ...

Cancer can affect anyone at any age. However, cancer is increasingly prevalent as we age, with most occurrences occurring in those 50 and older. It’s crucial to avoid attributing any odd changes, ...

Early signs of breast cancer may include a lump or ... or thickened skin around the nipple or areola may be a sign of Paget’s disease of the nipple. This is a rare type of breast cancer, but ...

Teva stock catapulted Tuesday after its inflammatory bowel disease treatment showed "best-in-class potential" in a Phase 2 ...